文献检索
文档翻译
深度研究
Zotero 插件
邀请有礼
套餐&价格
历史记录
Suppr
超能文献
应用&插件
Topical BCG for recurrent superficial bladder cancer.
出版信息
Lancet. 1991 Apr 6;337(8745):821-2.
PMID:
1672916
Abstract
摘要
文献AI研究员
20分钟写一篇综述,助力文献阅读效率提升50倍。
立即体验
用中文搜PubMed
大模型驱动的PubMed中文搜索引擎
马上搜索
文档翻译
学术文献翻译模型,支持多种主流文档格式。
立即体验
应用&插件
Zotero 插件
浏览器插件
Mac 客户端
Windows 客户端
微信小程序
定价
高级版会员
购买积分包
购买API积分包
服务
文献检索
文档翻译
深度研究
API 文档
MCP 服务
关于我们
关于 Suppr
公司介绍
联系我们
用户协议
隐私条款
关注我们
Suppr 超能文献
核心技术专利:
CN118964589B
侵权必究
粤ICP备2023148730 号-1
Suppr @ 2026
相似文献
1
Topical BCG for recurrent superficial bladder cancer.
局部卡介苗用于复发性浅表性膀胱癌
Lancet. 1991 Apr 6;337(8745):821-2.
2
[Results obtained by intravesical instillation of BCG in superficial bladder tumors].
[卡介苗膀胱内灌注治疗浅表性膀胱肿瘤的结果]
Orv Hetil. 1990 Jan 7;131(1):25-8.
3
BCG in the management of superficial bladder cancer.
Prog Clin Biol Res. 1985;185B:161-6.
4
[ImmuCyst intravesical (freeze-dried preparation made from the connaught strain of Bacillus Calmette Guérin) for the treatment of superficial bladder cancer and carcinoma in situ of urinary bladder].
[免疫膀胱内灌注剂(由卡介苗康诺特菌株制成的冻干制剂)用于治疗浅表性膀胱癌和膀胱原位癌]
Gan To Kagaku Ryoho. 2003 Jul;30(7):1027-38.
5
BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer.
用于浅表性膀胱癌的卡介苗-荷兰国家公共卫生与环境研究所膀胱内免疫预防
Prog Clin Biol Res. 1988;269:511-24.
6
BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.
卡介苗(荷兰国家公共卫生与环境研究所株)与丝裂霉素膀胱内灌注治疗浅表性膀胱癌患者的疗效比较。欧洲癌症研究与治疗组织泌尿生殖系统肿瘤协作组和荷兰东南部协作组
Prog Clin Biol Res. 1989;303:435-46.
7
Intravesical administration of bacillus Calmette-Guérin in patients with recurrent superficial carcinoma of the urinary bladder: report of a prospective, randomized trial.
卡介苗膀胱内灌注治疗复发性膀胱浅表癌患者:一项前瞻性随机试验报告。
Cancer Treat Rep. 1985 Jan;69(1):47-53.
8
[Repeated yearly BCG treatment in superficial bladder cancer].
[浅表性膀胱癌的每年重复卡介苗治疗]
Orv Hetil. 1989 Mar 26;130(13):671-3.
9
BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale, design, and interim analysis of the trial of the South-East Cooperative Urological Group, The Netherlands.
卡介苗-荷兰国家公共卫生与环境研究所(BCG-RIVM)、卡介苗-蒂策(BCG-Tice)与丝裂霉素-C治疗浅表性膀胱癌的比较。荷兰东南合作泌尿外科组试验的原理、设计与中期分析
Prog Clin Biol Res. 1992;378:59-67.
10
BCG vaccine therapy for treatment of superficial bladder cancer.
卡介苗疫苗疗法用于浅表性膀胱癌的治疗。
Int Urol Nephrol. 1989;21(3):305-12. doi: 10.1007/BF02559741.
引用本文的文献
1
Tumour-cell-induced production of tumour necrosis factor by monocytes of gastric cancer patients receiving BCG immunotherapy.
接受卡介苗免疫疗法的胃癌患者单核细胞在肿瘤细胞诱导下产生肿瘤坏死因子。
Cancer Immunol Immunother. 1993;36(2):127-32. doi: 10.1007/BF01754413.
2
Pulmonary tuberculosis due to bacille Calmette-Guérin.
卡介苗所致肺结核
Clin Investig. 1993 Oct;71(10):787-90. doi: 10.1007/BF00190319.
3
Clinical and immunological effect of intravesical interleukin-2 on superficial bladder cancer.
膀胱内注射白细胞介素-2对浅表性膀胱癌的临床及免疫学效应
Cancer Immunol Immunother. 1994 Jul;39(1):68-70. doi: 10.1007/BF01517183.
4
Correlation between class I antigen expression and the ability to generate tumour infiltrating lymphocytes from bladder tumour biopsies.
I类抗原表达与从膀胱肿瘤活检样本中生成肿瘤浸润淋巴细胞的能力之间的相关性。
Br J Cancer. 1991 Dec;64(6):996-1000. doi: 10.1038/bjc.1991.454.
5
Immunomodulators. Future prospects.
免疫调节剂。未来展望。
Pharm Weekbl Sci. 1992 Aug 21;14(4A):245-52. doi: 10.1007/BF01962546.